STSM Grantees
| Grantee | Home institution | Host institution | Project title | Dates | |||
|---|---|---|---|---|---|---|---|
| Ms Nikoletta Szemerédi | University of Szeged | University of Chemistry and Technology Prague | Anticancer and antibacterial activity of selenocompounds | 20.01.2020 to 14.02.2020 | |||
| Ms Preeta Ananthanarayanan | Università degli Studi di Torino | AO Research Institute Davos | Engineering Novel Acoustic Wave Programmed Cancer organoid models for the study of malignant pleural mesothelioma | 10.01.2020 to 10.04.2020 | |||
| Mr Ozan Topcu | İstanbul Medipol Üniversitesi | Institute of Cancer Research Vienna | 06.01.2020 to 10.02.2020 | ||||
| Dr. Anamaria Brozovic | Rudjer Boskovic Institute | Heinrich Heine University Düsseldorf | Molecular mechanisms of concomitant resistance of carboplatin resistant ovarian cancer cells to paclitaxel | 05.11.2019 to 19.12.2019 | |||
| Mr. Juran Kralj | Rudjer Boskovic Institute | Heinrich Heine University Düsseldorf | Training in mRNA profiling | 29.03.2019 to 13.04.2019 | |||
| Ms. Ntungwe Epole Ngolle | Universidade Lusófona de Humanidades e Tecnologias | University of Szeged | Isolation, characterization and cytotoxicity study of royleanones from Plectrathus mutabilis using centrifugal partition chromatography (CPC) | 20.03.2019 to 10.04.2019 | |||
| Ms. Annamária Kincses | University of Szeged | Rudjer Boskovic Institute | Investigation of antioxidant property of thiosemicarbazones and their copper(II) complexes | 18.03.2019 to 31.03.2019 | |||
| Ms. Márta Nové | University of Szeged | Rudjer Boskovic Institute | Investigation of antioxidant property of thiosemicarbazones and their copper(II) complexes | 18.03.2019 to 31.03.2019 | |||
| Ms. Isabella Poetsch | Institute of Cancer Research Vienna | Università degli Studi di Torino | Analysis of triple action Pt(IV) compounds in MDR cancer therapy | 15.03.2019 to 15.04.2019 | |||
| Ms. Magdalena Hübner | ScienceConsult - DI | Centro de Investigación del Cáncer (CiC-IBMCC) | Studying drug-target networks in the are of cancer, cancer-genes, cancer-drugs and tumor resistance to explore and identify drug-target modules that may be involved in multi-drug resistance | 14.03.2019 to 16.04.2019 | |||
| Dr. Kornél Szőri | University of Szeged | Polish Academy of Sciences | Synthesis of p-quinol derivates as potent MDR-selective antitumor agents | 11.03.2019 to 13.04.2019 | |||
| Ms. Mirna Jovanovic | IBISS, University of Belgrade | Latvian Institute of Organic Synthesis | Investigation of inhibitory properties of Michael acceptors on thioredoxin reductase 1 inhibition in vitro | 18.02.2019 to 29.03.2019 | |||